Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancers - Anus”

351 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 351 results

Early research (Phase 1)Not Yet RecruitingNCT06358053
What this trial is testing

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Who this might be right for
Cervical CancerAnal CancerHead and Neck Cancers+1 more
Corregene Biotechnology Co., Ltd 24
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Not applicableEnded earlyNCT02503111
What this trial is testing

The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men

Who this might be right for
Anal DysplasiaHuman PapillomavirusAnal Cancer
University Health Network, Toronto 71
Not applicableStudy completedNCT01104181
What this trial is testing

Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test

Who this might be right for
Anal Canal HPV Infection DiagnosisAnal Dysplasia DiagnosisAnal Cancer
Laser Surgery Care 300
Not applicableActive Not RecruitingNCT04713618
What this trial is testing

Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy

Who this might be right for
Anal CarcinomaCervical CarcinomaEndometrial Carcinoma+4 more
Ohio State University Comprehensive Cancer Center 72
Testing effectiveness (Phase 2)UnknownNCT03944252
What this trial is testing

Cetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS)

Who this might be right for
Squamous Cell Anal Carcinoma
Gruppo Oncologico del Nord-Ovest 54
Early research (Phase 1)Study completedNCT00066430
What this trial is testing

Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

Who this might be right for
Anal CancerPrecancerous Condition
AIDS Malignancy Consortium 18
Not applicableUnknownNCT01388257
What this trial is testing

Anal Crohn Fistula Surgery

Who this might be right for
Crohn DiseaseFistulaAnoperineal Fistula+1 more
French Society of Coloproctology 180
Not applicableStudy completedNCT05682157
What this trial is testing

Paula Method of Exercises in Patients With LARS Syndrome:Randomized Controlled Trial

Who this might be right for
Low Anterior Resection Syndrome
Hadassah Medical Organization 62
Testing effectiveness (Phase 2)Looking for participantsNCT06050707
What this trial is testing

MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

Who this might be right for
Anal Squamous Cell Carcinoma
University Health Network, Toronto 80
Early research (Phase 1)WithdrawnNCT00780988
What this trial is testing

Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsAnal, Colon, and Rectal Cancers
Stanford University
Not applicableStudy completedNCT06048146
What this trial is testing

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

Who this might be right for
Lymph Node MetastasisCancer of Rectum and AnusOxaliplatin+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Not applicableStudy completedNCT02145416
What this trial is testing

ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy

Who this might be right for
Anal Cancer
University of Oxford 29
Large-scale testing (Phase 3)Active Not RecruitingNCT04444921
What this trial is testing

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaMetastatic Anal Squamous Cell Carcinoma+4 more
National Cancer Institute (NCI) 205
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Who this might be right for
Advanced CancerAnal CarcinomaAnal Cancer+22 more
Merck Sharp & Dohme LLC 1,609
Testing effectiveness (Phase 2)Study completedNCT03499795
What this trial is testing

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Who this might be right for
Anal Neoplasm
Inovio Pharmaceuticals 23
Early research (Phase 1)Looking for participantsNCT07217171
What this trial is testing

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Who this might be right for
Bladder CancerSquamous Cell Carcinoma of the LungEsophageal Squamous Cell Carcinoma+8 more
EvolveImmune United, Inc 160
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Load More Results